Suboptimal Effect of Daptomycin in the Treatment of Bacteremias

Overview

Journal South Med J

Specialties General Medicine
General Surgery

Date 1989 Nov 1

PMID 2554510

Citations 11

Authors

M W Garrison

J C Rotschafer

K B Crossley

Affiliations

Soon will be listed here.

Abstract

We have reported two cases involving bacteremic patients who failed to respond adequately to the investigational agent daptomycin. Despite apparent sensitivity of the organisms, therapy was unsuccessful in both patients using the recommended dosage. The sponsor of daptomycin is currently reevaluating the recommendation and may be revising their dosage guidelines in the future.

Citing Articles

High-Dose Daptomycin and Clinical Applications.

Jones T, Jun A, Michal J, Olney W Ann Pharmacother. 2021; 55(11):1363-1378.

PMID: 33535792 PMC: 8573721. DOI: 10.1177/1060028021991943.

Vancomycin-resistant enterococci.

Cetinkaya Y, Falk P, Mayhall C Clin Microbiol Rev. 2000; 13(4):686-707.

PMID: 11023964 PMC: 88957. DOI: 10.1128/CMR.13.4.686.

Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.

Houlihan H, Mercier R, Rybak M Antimicrob Agents Chemother. 1997; 41(11):2497-501.

PMID: 9371356 PMC: 164151. DOI: 10.1128/AAC.41.11.2497.

Current perspectives on glycopeptide resistance.

Woodford N, Johnson A, Morrison D, Speller D Clin Microbiol Rev. 1995; 8(4):585-615.

PMID: 8665471 PMC: 172877. DOI: 10.1128/CMR.8.4.585.

Bactericidal activities of peptide antibiotics against multidrug-resistant Enterococcus faecium.

Mobarakai N, Quale J, Landman D Antimicrob Agents Chemother. 1994; 38(2):385-7.

PMID: 8192473 PMC: 284464. DOI: 10.1128/AAC.38.2.385.